Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

Ashely Claudino is an Evergreen Staff Writer from Portugal. She has a Translation degree from the University of Lisbon (2020, Faculty of Arts and Humanities). She has been writing for Game Rant since ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Apple's iOS 26.4 and iOS 18.7.8 fix the same flaw, in Notification Services, where ...

Eli Lilly LLY0.87%increase; green up pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Daniel is a News Writer from the United Kingdom. Relatively new to the industry with just over three years of experience, he has focused on establishing himself in the gaming space, with bylines in ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. April 25 update: this article, originally published on April 22 was updated on April 25 with ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...

This page acts as a comprehensive breakdown of the Lord of Hatred expansion for Diablo 4, including a link to the full Patch Notes. Whispers have emerged through Skovos that a prophet has landed in ...

General Dynamics said the safety of soldiers 'is, and has always been, our highest priority'. Trials of the Army's troubled Ajax armoured vehicles will resume "cautiously", with the defence minister ...

Total consideration reaches up to $2.3 billion via upfront payment plus milestones tied to predefined clinical and regulatory achievements, subject to customary conditions and Hart-Scott-Rodino ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...